Gene: CHD2
Official Full Name: chromodomain helicase DNA binding protein 2provided by HGNC
Gene Summary: The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38572 | CHD2 Knockout cell line (HeLa) | Human | CHD2 | 1:3~1:6 | Negative | Online Inquiry |
KO38573 | CHD2 Knockout cell line (HCT 116) | Human | CHD2 | 1:2~1:4 | Negative | Online Inquiry |
KO38574 | CHD2 Knockout cell line (HEK293) | Human | CHD2 | 1:3~1:6 | Negative | Online Inquiry |
KO38575 | CHD2 Knockout cell line (A549) | Human | CHD2 | 1:3~1:4 | Negative | Online Inquiry |
CHD2 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to study the function of the CHD2 (Chromodomain Helicase DNA Binding Protein 2) gene. These cell lines have been created using advanced CRISPR-Cas9 genome-editing technology, resulting in the targeted disruption of the CHD2 gene, which plays a crucial role in chromatin remodeling, DNA repair, and gene expression regulation. By providing a controlled environment to observe the cellular consequences of CHD2 loss, these knockout cell lines enable researchers to dissect the molecular pathways and biological processes influenced by CHD2.
The primary mechanism of action involves the loss of CHD2 function, which can lead to altered chromatin structure and changes in gene transcription profiles. This can elucidate the gene's role in various biological contexts, such as cellular proliferation, differentiation, and response to DNA damage. Importantly, CHD2 has been implicated in several malignancies and neurological disorders, making these cell lines of significant interest in both cancer research and neurobiology.
In terms of scientific applications, CHD2 Gene Knockout Cell Lines are invaluable tools for investigating disease mechanisms, screening potential therapeutic agents, and understanding gene-environment interactions. Compared to alternative models, such as RNA interference or transient knockdown, these knockout lines provide a stable and permanent gene alteration, offering more reliable and reproducible results over extended experimental timelines.
For researchers and clinicians, the ability to study the CHD2 gene in detail is critical for developing targeted therapies and understanding complex diseases. Our commitment to innovation and quality ensures that our CHD2 Gene Knockout Cell Lines are backed by rigorous validation and characterized in accordance with industry standards, making them a trusted choice for cutting-edge research. With expertise in the development of advanced biological products, we strive to empower the scientific community with the tools necessary to push the boundaries of knowledge in genetic and molecular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.